John Snisarenko

Director, Alimera Sciences.

Companies

Alimera SciencesBoard member Jul 22, 2019 to Sep 18, 2024¹
Oyster Point Pharma, Inc.Chief Commercial Officer Oct 30, 2019 to Jan 11, 2022²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Alimera Sciences ALIM0 shares³Sep 16, 2024
Oyster Point Pharma, Inc.30,322 shares⁴Jan 9, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Sep 16, 2024Returned to company 10,000 shares of Alimera Sciences³
Jan 9, 2022Granted 12,100 shares of Oyster Point Pharma, Inc.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAlimera Sciences, Board member
2
SEC EDGAROyster Point Pharma, Inc., Chief Commercial Officer
3
SEC EDGARAlimera Sciences shares after the filing of Sep 16, 2024
4
SEC EDGAROyster Point Pharma, Inc. shares after the filing of Jan 9, 2022